PRADAXA
150MG CPS DUR 60X1 II
| SÚKL code | 0193506 |
|---|---|
| Name of the product | PRADAXA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | PRADAXA |
| Supplement | 150MG CPS DUR 60X1 II |
| Strenght | 150MG |
| Pharmaceutical form | Capsule, hard |
| Package | 60X1 II |
| Route | Oral use |
| Wrap type | |
| Legal status | na lékařský předpis |
| Active substance | DABIGATRAN ETEXILAT MESILATE (DABIGATRANI ETEXILATI MESILAS) |
| ATC group | B01AE07 |
| ATC group name | DABIGATRAN-ETEXILÁT |
Marketing authorisation information
| Registration Number | EU/1/08/442/019 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Boehringer Ingelheim International GmbH, Ingelheim am Rhein |
| MA Holder country | NĚMECKO |
cz